Genetically abnormal myocyte function160, 161
|
Ventricular hypertrophy (subendocardial ischemia)156, 162
|
Fibrosis111, 158
|
Hemodynamic overload (altered calcium‐handling)33
|
Increased myocardial wall stretch34, 163
|
Endothelial/microvascular dysfunction157, 164
|
Activation of the renin–angiotensin–aldosterone system165
|
Activation of the sympathetic nervous system (norepinephrine toxicity)30, 166, 167
|
Toxic effects of inflammatory cytokines168, 169
|
Oxidative stress170
|
Troponin autoimmunity171, 172
|
Systemic hypotension46, 173, 174
|
Anemia175
|
Arrhythmia90, 175, 176
|
Inotropic drugs46, 173, 174
|